-
Nanotechnology-Based Vaccine Candidate, Blood Type A Raises Risk, Neanderthal-Derived Protein Offers Protection: COVID-19 Updates
Bio-IT World I Variant that emerged in the UK could be more transmissible, SARS-CoV-2 may be particularly attracted to blood group A respiratory cells, a balanced T cell response is key to clearing virus without symptoms, and out-of-place large bone marrow cells responsible for brain fog. Plus: Heart muscle cells a target and could lead to cell death, interfere with heart muscle contraction and MIS-C patients have highly activated immune systems that are similar to adult COVID-19 patients.
Mar 5, 2021
-
Spatial Surge: AGBT Updates On Single-Cell and Spatial Genomics, In Situ Analysis, More
Bio-IT World | A host of sponsors and vendor companies attended the virtual AGBT General Meeting this week. Through sponsored talks and even more poster sessions, vendor companies shared their latest work and technology developments and made product announcements.
Mar 4, 2021
-
CRISPR For COVID-19: Approaches To Speeding Therapeutic Discovery
Bio-IT World | Neville Sanjana from the New York Genome Center and NYU turned his attention to COVID-19 early in the pandemic. For several years, his lab has focused on using CRISPR to identify which regions of the genome drive disease. Last year, he applied that expertise to using genome-wide CRISPR screens to look for COVID-19 risk factors.
Mar 3, 2021
-
Building A Telomere-to-Telomere Human Pangenome Reference
Bio-IT World | Our current version of the human reference genome does not adequately represent genetic diversity in the human population, Karen Miga told the virtual audience at this week’s AGBT General Meeting. The Human Pangenome Reference Consortium and the Telomere-to-Telomere Consortium are working to change that.
Mar 2, 2021
-
Updates To All of Us, First Genomic Results Returned To Participants
Bio-IT World | Josh Denny, CEO of NIH’s All of Us program, gave an update on the population sequencing program in the opening session of the virtual AGBT General Meeting this week.
Mar 1, 2021


